Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • No result with DESeq2, but with Cuffdiff 2.1.1

    I have a question, I get no significantly changed genes running DESeq2. I have two groups at two time points (paired) and ran DEseq2 v1.2. DESeq2 test the difference between groups, disregarding time point, difference between time points disregarding groups & finally if one group had another effect between the two timepoints than the other.

    I have also used Cuffdiff 2.1.1 testing difference between groups, disregarding time point & difference between time points disregarding groups (Cuffdiff cannot handle the last test).

    Cuffdiff found over 1000 diff exp. genes and running GAGE it all made biological sense. So why cant I find anything with DEseq2?

  • #2
    I haw tweeked abit and the results now looks ok, but differing still from cuffdiff. My study design is however one that cuffdiff cannot handle..

    Comment


    • #3
      If you told us what you actually did, we might be able to tell you whether it is correct. So, how have you called DESeq2?

      Comment


      • #4
        Hi!
        With this run I get some genes sig. changed and I guess they are more to be trusted than Cuffdiff results due to correct design?
        I will see if EdgeR also gives the same results.

        library(DESeq2);
        library(GenomicFeatures);
        library(htSeqTools);
        sampleFiles <- list.files(path="/Volumes/timemachine/HTseq_DEseq2",pattern="*.txt");
        sort(sampleFiles,decreasing=TRUE);
        status <- factor(c(rep("Diabetic",22), rep("Healthy",26)), levels=c("Diabetic","Healthy"));
        timepoints = as.factor(c(1,1,1,1,1,1,1,1,1,1,1,2,2,2,2,2,2,2,2,2,2,2,1,1,1,1,1,1,1,1,1,1,1,1,1,2,2,2,2,2,2,2,2,2,2,2,2,2));
        patients <- factor(c(88,87,86,83,82,81,75,72,71,70,13,08,01,88,87,86,83,82,81,75,72,71,70,13,08,01,79,77,76,73,67,62,61,55,53,21,04,79,77,76,73,67,62,61,55,53,21,04));
        sampleTable <- data.frame(sampleName = sampleFiles, fileName = sampleFiles, status=status, timepoints=timepoints, patients=patients);
        directory <- c("/Volumes/timemachine/HTseq_DEseq2/");
        des <- formula(~patients + timepoints*status);
        ddsHTSeq <- DESeqDataSetFromHTSeqCount(sampleTable = sampleTable, directory = directory, design= des);
        ddsHTSeq;
        dds <- estimateSizeFactors(ddsHTSeq);
        dds <- estimateDispersions(dds);
        dds <- nbinomWaldTest(dds, maxit = 5000)
        resultsNames(dds);
        statusResults <- results(dds, "status_Healthy_vs_Diabetic");
        timepointsResults <- results(dds, "timepoints_2_vs_1");
        statusTreatmentResults <- results(dds, "timepoints2.statusHealthy");
        write.csv(as.data.frame(statusResults),file="/Volumes/timemachine/HTseq_DEseq2/1_Results/statusResults.csv");
        write.csv(as.data.frame(timepointsResults),file="/Volumes/timemachine/HTseq_DEseq2/1_Results/timepointsResults.csv");
        write.csv(as.data.frame(statusTreatmentResults),file="/Volumes/timemachine/HTseq_DEseq2/1_Results/statusTreatmentResults.csv");
        plotDispEsts(dds)
        Last edited by sindrle; 10-21-2013, 12:30 AM.

        Comment

        Latest Articles

        Collapse

        • seqadmin
          Current Approaches to Protein Sequencing
          by seqadmin


          Proteins are often described as the workhorses of the cell, and identifying their sequences is key to understanding their role in biological processes and disease. Currently, the most common technique used to determine protein sequences is mass spectrometry. While still a valuable tool, mass spectrometry faces several limitations and requires a highly experienced scientist familiar with the equipment to operate it. Additionally, other proteomic methods, like affinity assays, are constrained...
          04-04-2024, 04:25 PM
        • seqadmin
          Strategies for Sequencing Challenging Samples
          by seqadmin


          Despite advancements in sequencing platforms and related sample preparation technologies, certain sample types continue to present significant challenges that can compromise sequencing results. Pedro Echave, Senior Manager of the Global Business Segment at Revvity, explained that the success of a sequencing experiment ultimately depends on the amount and integrity of the nucleic acid template (RNA or DNA) obtained from a sample. “The better the quality of the nucleic acid isolated...
          03-22-2024, 06:39 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by seqadmin, 04-11-2024, 12:08 PM
        0 responses
        22 views
        0 likes
        Last Post seqadmin  
        Started by seqadmin, 04-10-2024, 10:19 PM
        0 responses
        24 views
        0 likes
        Last Post seqadmin  
        Started by seqadmin, 04-10-2024, 09:21 AM
        0 responses
        19 views
        0 likes
        Last Post seqadmin  
        Started by seqadmin, 04-04-2024, 09:00 AM
        0 responses
        50 views
        0 likes
        Last Post seqadmin  
        Working...
        X